Novartis AG is 68.2x more valuable than Tango Therapeutics, Inc. by market capitalization ($283.13 B vs $4.15 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TNGX | NVS |
|---|---|---|
| Market cap | $4.15 B | $283.13 B |
| US-listed rank | #1540 | #47 |
| Revenue (latest FY) | $62.38M | - |
| Net income (latest FY) | -$101.60M | - |
| Net margin | -162.9% | - |
| SEC filings | 382 | 947 |
Novartis AG is 68.2x more valuable than Tango Therapeutics, Inc. by market capitalization ($283.13 B vs $4.15 B).
Full pages: Tango Therapeutics, Inc. and Novartis AG, or browse the full rankings.